Corient Private Wealth LP Acquires New Shares in HCA Healthcare, Inc. $HCA

Corient Private Wealth LP bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 103,425 shares of the company’s stock, valued at approximately $40,325,000.

A number of other institutional investors have also recently added to or reduced their stakes in HCA. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at $26,000. Cedar Mountain Advisors LLC acquired a new position in HCA Healthcare in the first quarter valued at approximately $33,000. MCF Advisors LLC increased its stake in HCA Healthcare by 213.0% in the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after purchasing an additional 49 shares in the last quarter. MidFirst Bank acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at about $28,000. Finally, Clearstead Trust LLC acquired a new position in HCA Healthcare during the 2nd quarter worth approximately $29,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently issued reports on HCA shares. Robert W. Baird cut their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a report on Tuesday, July 7th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Barclays dropped their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Finally, TD Cowen reduced their price objective on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Trading Down 1.9%

Shares of HCA stock opened at $419.19 on Friday. The firm’s 50 day moving average is $400.24 and its 200 day moving average is $441.63. The stock has a market capitalization of $90.75 billion, a P/E ratio of 14.03, a PEG ratio of 1.48 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter last year, the company earned $6.84 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.